350: Pharma tariffs, and a 'sunshine day' for biotech stocks
The Readout Loud
00:00
Lawsuits and Drug Manufacturing Dilemmas
This chapter explores a high-profile lawsuit against a biotech entrepreneur with a controversial background, addressing allegations of misconduct involving unapproved veterinary medicine. It also examines the implications of pharmaceutical tariffs, the emergence of Ireland as a key manufacturing hub, and the challenges of bringing production back to the U.S. The discussion culminates with insights from a personal trip to Ireland, reflecting on the economic impact of local biotech facilities.
Transcript
Play full episode
